Remedy Cell Ltd.

About

Funding history · 3 rounds · $18.0M total

Q&A

What is Remedy Cell Ltd.'s primary focus?

Remedy Cell Ltd. is a clinical-stage biopharmaceutical company focused on the discovery and development of cell-derived, cell-free, breakthrough secretome therapies for fibrotic diseases.

When was Remedy Cell Ltd. founded?

Remedy Cell Ltd. was founded in 2020.

What is Remedy Cell Ltd.'s lead product and its current clinical trial status?

Remedy Cell Ltd.'s lead product, RC-0315, is currently in a Phase 1b clinical trial for Idiopathic Pulmonary Fibrosis (IPF).

What is the name of Remedy Cell Ltd.'s proprietary technology platform?

Remedy Cell Ltd. utilizes its proprietary Activated Remedy cell Secretome (ARcS) platform.

How much funding has Remedy Cell Ltd. raised to date?

Remedy Cell Ltd. has raised a total of $18,000,000 USD.

When did Remedy Cell Ltd. complete its Seed funding round and who were the lead investors?

In May 2025, Remedy Cell Ltd. completed a Seed funding round, with.

Where is Remedy Cell Ltd. headquartered?

Remedy Cell Ltd. is headquartered in Haifa, Israel.

Who are the founders of Remedy Cell Ltd.?

The founders of Remedy Cell Ltd. include Ayelet Dilion Mashiah, Prof. Yuval Shaked, and Dr. Michael Timaner.

Team · 9

Ayelet Dilion Mashiah

Founder · Chief Executive Officer

Prof. Yuval Shaked

Founder · Co-Founder and Chief Scientific Advisor

Dr. Michael Timaner

Founder · Vice President, Research and Development

Dr. Tali Fishman-Jacob

Director, Preclinical Development

Marina Meital Melamud

Process Development Manager

Eden Yonatan Shimshoni

Research and Development Scientist

Dr. Marina Khutorian

Portfolio Development & QA Manager

Katrin Berger

HR and Administration Manager

Dr. Paul Ford

Chief Medical Officer

Sectors & technology